We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bespak | LSE:BPK | London | Ordinary Share | GB0000946276 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 667.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:8481D Bespak PLC 14 September 2007 Bespak - Interim Management Statement Bespak plc, a leader in medical devices for inhaled drug delivery and anaesthesia, issues today its Interim Management Statement for the period, 29 April 2007 to 14 September 2007. Trading for period has been in line with the Board's expectations with good performances in both our inhaled drug delivery and anaesthesia segments. On 27 June 2007 we announced that Nektar Therapeutics and Pfizer had revised their short term forecasts for their Exubera(R) inhalation device and as a result we were embarking on a consultation process with our employees involved in its production. We remain in detailed discussions with Nektar on potential strategies to address the short- to medium-term supply of the Exubera(R) inhaler. On 17 July 2007, we acquired, for a modest consideration, through a newly formed subsidiary company (Integrated Aluminium Components Limited), certain assets of Decorpart Ltd from its administrators. Decorpart produces ferrules used in our metered dose inhaler valves and this acquisition secures the supply chain for our business, and supplies third parties. The Company will hold its AGM on September 26th 2007 and publish interim results in December 2007. For further information, please contact: Bespak plc Mark Throdahl, Chief Executive Tel: +44 (0) 1908 552600 Jonathan Glenn, Group Finance Director Maitland Liz Morley Tel: +44 (0) 207 3795151 Brian Hudspith This Interim Management Statement is prepared for and addressed only to the Company's shareholders as a whole and to no other person. The Company, its directors, employees, agents or advisers do not accept or assume responsibility to any other person to whom this Interim Management Statement is shown or into whose hands it may come and any such responsibility or liability is expressly disclaimed. Statements contained in this Interim Management Statement are based on the knowledge and information available to the Company's Directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Interim Management Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. To the extent that this Interim Management Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward-looking statements. About Bespak plc Bespak plc is a leader in medical devices for inhaled drug delivery and anaesthesia. The Group develops drug delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings in hospitals. Bespak develops and manufactures metered dose inhaler valves, actuators, compliance aids, dry powder devices, disposable face masks, breathing circuits and laryngeal tubes. The Group has facilities in King's Lynn and Milton Keynes in the UK, Indianapolis, Indiana and Kent, Ohio in the US, and a liaison office in Mumbai, India. Bespak is a public company quoted on the full list of the London Stock Exchange (LSE: BPK). For more information, please visit www.bespak.com This information is provided by RNS The company news service from the London Stock Exchange END IMSGUURUBUPMGRW
1 Year Bespak Chart |
1 Month Bespak Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions